For the CRCHUM conference taking place on May 26, 2017, Monsef Benkirane from the Institut de génétique humaine in France, will speak about recent discovery of his team related to HIV reservoir.
Persistence of HIV reservoir in infected individuals under suppressive antiretroviral therapy is the major obstacle to achieve HIV cure. I will present our recent discovery that CD32a+ lymphocytes harbor the elusive HIV-1 reservoir. This finding may lead to insights that will facilitate the specific targeting and elimination of the viral reservoir.
Guest of Petronela Ancuta, theme: Tissue injury, infection, immunity and inflammation
This conference will be presented in English.
Friday, May 26, 2017, at Noon.
Auditorium of the CRCHUM , R05.210 and R05.220
900 Saint-Denis Street, 5th floor
Montréal (Quebec) H2X 0A9
Monsef Benkirane, Ph.D.
Researcher, Head of the Molecular Virology Laboratory
Institut de génétique humaine, CNRS, France
About CRCHUM Conferences
The CRCHUM Conferences are free weekly meetings featuring renowned scientific speakers from various disciplines. These conferences are accredited by the Royal College of Physicians and Surgeons of Canada as continuing professional development activities. The CRCHUM conferences are made possible thanks to the financial support of our partners: AstraZeneca, GSK, Lilly, Merck, Roche & Servier.